Cadila Healthcare informs about press release

30 Jun 2018 Evaluate

Cadila Healthcare has informed about press release titled, 'Zydus receives final approval from the USFDA for Triamterene and Hydrochlorothiazide Tablets USP'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

963.50 15.60 (1.65%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.